| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aeee8d3f65d495ab7c77f7132d3b5da2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
2000-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0e4e19288fef1616283811de4acc95f |
| publicationDate |
2002-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6498145-B1 |
| titleOfInvention |
Use of purified SDG as a hypotensive (vasodilator) agent |
| abstract |
The compound secoisolariciresinol diglucoside (SDG), obtained from flaxseed is used for treating hypertension or for reducing or preventing the development of elevated blood pressure in humans or animals. These uses include the treatment of ischemic heart disease, heart failure and intermittent claudication. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7048960-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7595078-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1491099-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003180436-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2130544-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006210691-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014083171-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005158435-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1491099-A1 |
| priorityDate |
1999-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |